Comprehensive analysis of complications after transperineal prostate biopsy without antibiotic prophylaxis: results of a multicenter trial with 30 days' follow-up.
Journal
Prostate cancer and prostatic diseases
ISSN: 1476-5608
Titre abrégé: Prostate Cancer Prostatic Dis
Pays: England
ID NLM: 9815755
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
received:
11
02
2021
accepted:
28
06
2021
revised:
21
06
2021
pubmed:
17
7
2021
medline:
14
6
2022
entrez:
16
7
2021
Statut:
ppublish
Résumé
To investigate infectious and non-infectious complications after transperineal prostate biopsy (TPB) without antibiotic prophylaxis in a multicenter cohort. Secondly, to identify whether increasing the number of cores was predictive for the occurrence of complications. Thirdly, to examine the relation between TPB and erectile dysfunction. We analyzed a retrospective multicenter cohort of 550 patients from three different urological centers undergoing TPB without antibiotic prophylaxis. The median number of cores was 26. Demographic and clinical data were extracted by reviewing patients' electronic medical records and follow-up data such as postoperative complications obtained by structured phone interviews. To investigate the influence of the number of cores taken on the occurrence of complications, we performed univariate and multivariate mixed effects logistic regression models. There was no case of sepsis reported. Overall, 6.0% of patients (33/550) presented with any complication besides mild macrohematuria. In all, 46/47 (98%) complications were ≤Grade 2 according to Clavien-Dindo. In multivariate regression analyses, an increased number of cores was associated with overall complications (odds ratio (OR) 1.08, 95% confidence interval (CI) 1.02-1.14, P = 0.01) and specifically bleeding complications (OR 1.28, 95% CI 1.11-1.50, P = 0.01) but not with infectious complications (OR 1.03, 95% CI 0.97-1.10, P = 0.67). A total of 14.4% of patients referred impairment of erectile function after TPB. Of note, 98% of these men were diagnosed with prostate cancer. This is the first multicenter trial to investigate complications after TPB without antibiotic prophylaxis. In our study, we found no case of sepsis. This underlines the safety advantage of TPB even without antibiotic prophylaxis and supports the ongoing initiative to abandon TRB of the prostate. A higher number of cores were associated with an increase in overall complications specifically bleeding complications, but not with infectious complications. Post-biopsy erectile dysfunction was mainly present in patients diagnosed with PCa.
Sections du résumé
BACKGROUND
To investigate infectious and non-infectious complications after transperineal prostate biopsy (TPB) without antibiotic prophylaxis in a multicenter cohort. Secondly, to identify whether increasing the number of cores was predictive for the occurrence of complications. Thirdly, to examine the relation between TPB and erectile dysfunction.
METHODS
We analyzed a retrospective multicenter cohort of 550 patients from three different urological centers undergoing TPB without antibiotic prophylaxis. The median number of cores was 26. Demographic and clinical data were extracted by reviewing patients' electronic medical records and follow-up data such as postoperative complications obtained by structured phone interviews. To investigate the influence of the number of cores taken on the occurrence of complications, we performed univariate and multivariate mixed effects logistic regression models.
RESULTS
There was no case of sepsis reported. Overall, 6.0% of patients (33/550) presented with any complication besides mild macrohematuria. In all, 46/47 (98%) complications were ≤Grade 2 according to Clavien-Dindo. In multivariate regression analyses, an increased number of cores was associated with overall complications (odds ratio (OR) 1.08, 95% confidence interval (CI) 1.02-1.14, P = 0.01) and specifically bleeding complications (OR 1.28, 95% CI 1.11-1.50, P = 0.01) but not with infectious complications (OR 1.03, 95% CI 0.97-1.10, P = 0.67). A total of 14.4% of patients referred impairment of erectile function after TPB. Of note, 98% of these men were diagnosed with prostate cancer.
CONCLUSIONS
This is the first multicenter trial to investigate complications after TPB without antibiotic prophylaxis. In our study, we found no case of sepsis. This underlines the safety advantage of TPB even without antibiotic prophylaxis and supports the ongoing initiative to abandon TRB of the prostate. A higher number of cores were associated with an increase in overall complications specifically bleeding complications, but not with infectious complications. Post-biopsy erectile dysfunction was mainly present in patients diagnosed with PCa.
Identifiants
pubmed: 34267332
doi: 10.1038/s41391-021-00423-3
pii: 10.1038/s41391-021-00423-3
pmc: PMC9184280
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
264-268Informations de copyright
© 2021. The Author(s).
Références
Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2017;71:618–29.
doi: 10.1016/j.eururo.2016.08.003
Grummet JP, Weerakoon M, Huang S, Lawrentschuk N, Frydenberg M, Moon DA, et al. Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy? BJU Int. 2014;114:384–8.
pubmed: 24612341
Johansen TEB, Zahl PH, Baco E, Bartoletti R, Bonkat G, Bruyere F, et al. Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry. World J Urol. 2020;38:17–26.
doi: 10.1007/s00345-019-02837-0
Xiang J, Yan H, Li J, Wang X, Chen H, Zheng X. Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis. World J Surg Oncol. 2019;17:31.
doi: 10.1186/s12957-019-1573-0
Pepe P, Garufi A, Priolo G, Pennisi M. Transperineal versus transrectal MRI/TRUS fusion targeted biopsy: detection rate of clinically significant prostate cancer. Clin Genitourin Cancer. 2017;15:e33–6.
doi: 10.1016/j.clgc.2016.07.007
Ventola CL. The antibiotic resistance crisis: part 2: management strategies and new agents. P T. 2015;40:344–52.
pubmed: 25987823
pmcid: 4422635
Nickel JC, Doiron RC. Dangerous fluoroquinolones: the urologist’s dilemma. Can Urol Assoc J. 2020;14:85–6.
pubmed: 32254009
pmcid: 7124167
doi: 10.5489/cuaj.6498
Kroenig M, Schaal K, Benndorf M, Soschynski M, Lenz P, Krauss T, et al. Diagnostic accuracy of robot-guided, software based transperineal MRI/TRUS fusion biopsy of the prostate in a high risk population of previously biopsy negative men. BioMed Res Int. 2016;2016:1–6. https://www.hindawi.com/journals/bmri/2016/2384894/.
doi: 10.1155/2016/2384894
Kuru TH, Roethke M, Popeneciu V, Teber D, Pahernik S, Zogal P, et al. Phantom study of a novel stereotactic prostate biopsy system integrating preinterventional magnetic resonance imaging and live ultrasonography fusion. J Endourol. 2012;26:807–13.
doi: 10.1089/end.2011.0609
Kuru TH, Wadhwa K, Chang RT, Echeverria LM, Roethke M, Polson A, et al. Definitions of terms, processes and a minimum dataset for transperineal prostate biopsies: a standardization approach of the Ginsburg Study Group for Enhanced Prostate Diagnostics. BJU Int. 2013;112:568–77.
doi: 10.1111/bju.12132
Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13. http://journals.lww.com/00000658-200408000-00003.
doi: 10.1097/01.sla.0000133083.54934.ae
R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2010.
Vyas L, Acher P, Kinsella J, Challacombe B, Chang RT, Sturch P, et al. Indications, results and safety profile of transperineal sector biopsies (TPSB) of the prostate: a single centre experience of 634 cases. BJU Int. 2014;114:32–7.
doi: 10.1111/bju.12282
Ding XF, Luan Y, Lu SM, Zhou GC, Huang TB, Zhu LY, et al. Risk factors for infection complications after transrectal ultrasound-guided transperineal prostate biopsy. World J Urol. 2020. Online ahead of print.
Gorin MA, Meyer AR, Zimmerman M, Harb R, Joice GA, Schwen ZR, et al. Transperineal prostate biopsy with cognitive magnetic resonance imaging/biplanar ultrasound fusion: description of technique and early results. World J Urol. 2020;38:1943–9.
doi: 10.1007/s00345-019-02992-4
Wetterauer C, Shahin O, Federer-Gsponer JR, Keller N, Wyler S, Seifert HH, et al. Feasibility of freehand MRI/US cognitive fusion transperineal biopsy of the prostate in local anaesthesia as in-office procedure-experience with 400 patients. Prostate Cancer Prostatic Dis. 2020;23:429–34.
doi: 10.1038/s41391-019-0201-y
Huang GL, Kang CH, Lee WC, Chiang PH. Comparisons of cancer detection rate and complications between transrectal and transperineal prostate biopsy approaches – a single center preliminary study. BMC Urol. 2019;19:101.
doi: 10.1186/s12894-019-0539-4
Gunzel K, Heinrich S, Schlegel J, Ri C, Schostak M, Magheli A, et al. [Initial results of perineal MRI/ultrasound fusion biopsies under local anesthesia without standard perioperative antibiotic prophylaxis]. Der Urol Ausg A. 2020;59:1225–30.
Grummet J, Gorin MA, Popert R, O’Brien T, Lamb AD, Hadaschik B, et al. “TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now. Prostate Cancer Prostatic Dis. 2020;23:62–5.
doi: 10.1038/s41391-020-0204-8
Pilatz A, Veeratterapillay R, Dimitropoulos K, Omar MI, Pradere B, Yuan Y, et al. European association of urology position paper on the prevention of infectious complications following prostate biopsy. Eur Urol. 2021;79:11–5.
doi: 10.1016/j.eururo.2020.10.019
Pepe P, Aragona F. Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores. Urology. 2013;81:1142–6. https://linkinghub.elsevier.com/retrieve/pii/S0090429513002197.
doi: 10.1016/j.urology.2013.02.019
Helfand BT, Glaser AP, Rimar K, Zargaroff S, Hedges J, McGuire BB, et al. Prostate cancer diagnosis is associated with an increased risk of erectile dysfunction after prostate biopsy. BJU Int. 2013;111:38–43.
doi: 10.1111/j.1464-410X.2012.11268.x